Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
TXMD
— TherapeuticsMD, Inc.
NASDAQ
FULL STOCK PAGE →
Q2 2022 Earnings Call Summary
AUG 15, 2022
REVENUE
$28.6M
+47.7%
NET MARGIN
393.1%
+764.6 PTS
EPS
$12.83
+253.5%
FREE CASH FLOW
-$15.5M
+47.9%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →